Abstract:PURPOSE:To determine thrombospondin-2 (TSP2) expression and its impact on postnatal retinal vascular development and retinal neovascularization.METHODS:The TSP2-deficient (TSP2(-/-)) mice and a line of TSP2 reporter mice were used to assess the expression of TSP2 during postnatal retinal vascular development and neovascularization. The postnatal retinal vascularization was evaluated using immunostaining of wholemount retinas prepared at different postnatal days by collagen IV staining and/or TSP2 promoter driven green fluorescent protein (GFP) expression. The organization of astrocytes was evaluated by glial fibrillary acidic protein (GFAP) staining. Retinal vascular densities were determined using trypsin digestion preparation of wholemount retinas at 3- and 6-weeks of age. Retinal neovascularization was assessed during the oxygen-induced ischemic retinopathy (OIR). Choroidal neovascularization (CNV) was assessed using laser-induced CNV.RESULTS:Using the TSP2-GFP reporter mice, we observed significant expression of TSP2 mRNA in retinas of postnatal day 5 (P5) mice, which increased by P7 and remained high up to P42. Similar results were observed in retinal wholemount preparations, and western blotting for GFP with the highest level of GFP was observed at P21. In contrast to high level of mRNA at P42, the GFP fluorescence or protein level was dramatically downregulated. The primary retinal vasculature developed at a faster rate in TSP2(-/-) mice compared with TSP2(+/+) mice up to P5. However, the developing retinal vasculature in TSP2(+/+) mice caught up with that of TSP2(-/-) mice after P7. No significant differences in retinal vascular density were observed at 3- or 6-weeks of age. TSP2(-/-) mice also exhibited a similar sensitivity to the hyperoxia-mediated vessel obliteration and similar level of neovascularization during OIR as TSP2(+/+) mice. Lack of TSP2 expression minimally affected laser-induced CNV compared with TSP2(+/+) mice.CONCLUSIONS:Lack of TSP2 expression was associated with enhanced retinal vascularization during early postnatal days but not at late postnatal times, and minimally affected retinal and CNV. However, the utility of TSP2 as a potential therapeutic target for inhibition of ocular neovascularization awaits further investigation.

S1P Transporter SPNS2 Regulates Proper Postnatal Retinal Morphogenesis

Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells

The Role of Sphingosine-1-Phosphate Transporter Spns2 in Immune System Function

The Role of Sphingosine-1-Phosphate Receptor 2 in Mouse Retina Light Responses

SPNS1 is required for the transport of lysosphingolipids and lysoglycerophospholipids from lysosomes

Molecular basis of Spns2-facilitated sphingosine-1-phosphate transport

Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization.

Spinster homolog 2 in cancers, its functions and mechanisms

Spinster Homolog 2 (spns2) Deficiency Causes Early Onset Progressive Hearing Loss.

Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells

S1PR2 Deficiency Enhances Neuropathic Pain Induced by Partial Sciatic Nerve Ligation

Mfsd2a and Spns2 are essential for sphingosine-1-phosphate transport in the formation and maintenance of the blood-brain barrier.

Lack of SPNS1 results in accumulation of lysolipids and lysosomal storage disease in mouse models

Shp2 in Myocytes is Essential for Cardiovascular and Neointima Development.

<i>Srgap2</i> suppression ameliorates retinal ganglion cell degeneration in mice

Spns1 is an iron transporter essential for megalin-dependent endocytosis.

Up-Regulation of SorCS1, an Important Sorting Receptor, in the Retina of a Form-Deprivation Rat Model.

Srgap2 suppression ameliorates retinal ganglion cell degeneration in mice

SRSF10 Regulates Proliferation of Neural Progenitor Cells and Affects Neurogenesis in Developing Mouse Neocortex.

Mechanistic insights into transport models of the sphingolipid transport protein, Spinster homolog 2 (Spns2), using MD simulations

Structural basis of Sphingosine-1-phosphate transport via human SPNS2